Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
6.15
+0.14 (2.33%)
At close: Nov 12, 2026, 4:00 PM EST
6.23
+0.08 (1.30%)
After-hours: Nov 12, 2026, 7:28 PM EST
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $484.04 million as of November 12, 2026. It is the 14,626th most valuable company in the world and the 2,727th biggest in the United States. Its market cap has increased by 109.08% in one year.
Market Cap
484.04M
Enterprise Value
455.67M
1-Year Change
109.08%
Global Rank
Country Rank
#2,727 United States
Category
ChartMarket Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $484.04M, an increase of 145.15%. That is a compound annual growth rate of 15.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 484.04M | 106.56% |
| Dec 31, 2025 | 234.33M | 54.11% |
| Dec 31, 2024 | 152.05M | -53.41% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 4, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oculis Holding AG | 468.55M |
| Gyre Therapeutics | 462.98M |
| Relmada Therapeutics | 455.48M |
| Arvinas | 453.16M |
| BlossomHill Therapeutics | 452.62M |
| Indaptus Therapeutics | 445.39M |
| Prothena Corporation | 439.55M |
| Assembly Biosciences | 434.70M |